This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 1998 Jun 20;351(9119):1890-1.

doi: 10.1016/S0140-6736(05)78844-9.

Fluticasone propionate for chronic obstructive pulmonary disease

A Morice

PMID: 9652700
DOI: 10.1016/S0140-6736(05)78844-9

Comment

Fluticasone propionate for chronic obstructive pulmonary disease

A Morice. Lancet. 1998.

. 1998 Jun 20;351(9119):1890-1.

doi: 10.1016/S0140-6736(05)78844-9.

Author

A Morice

PMID: 9652700
DOI: 10.1016/S0140-6736(05)78844-9

No abstract available

PubMed Disclaimer

Comment on

Inhaled steroids in COPD.
Barnes NC. Barnes NC. Lancet. 1998 Mar 14;351(9105):766-7. doi: 10.1016/s0140-6736(98)22011-3. Lancet. 1998. PMID: 9519941 No abstract available.
Multicentre randomised placebo-controlled trial of inhaled fluticasone propionate in patients with chronic obstructive pulmonary disease. International COPD Study Group.
Paggiaro PL, Dahle R, Bakran I, Frith L, Hollingworth K, Efthimiou J. Paggiaro PL, et al. Lancet. 1998 Mar 14;351(9105):773-80. doi: 10.1016/s0140-6736(97)03471-5. Lancet. 1998. PMID: 9519948 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
- Ovid Technologies, Inc.